Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Mallinckrodt
Merck
Colorcon
Moodys

Last Updated: May 19, 2022

Investigational Drug Information for Aspartame


✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Aspartame?

Aspartame is an investigational drug.

There have been 6 clinical trials for Aspartame. The most recent clinical trial was a Phase 3 trial, which was initiated on June 10th 2019.

The most common disease conditions in clinical trials are Diabetes Mellitus, Obesity, Abdominal, and Kidney Diseases. The leading clinical trial sponsors are University of Toronto, Medical University of South Carolina, and National Institute of Allergy and Infectious Diseases (NIAID).

There is one US patent protecting this investigational drug and twenty-two international patents.

Recent Clinical Trials for Aspartame
TitleSponsorPhase
Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to ColonoscopyUniversal Integrated Corp.Phase 3
Effects of Fenofibrate Therapy in Diabetic NephropathyNational Medical Research Council (NMRC), SingaporePhase 3
Effects of Fenofibrate Therapy in Diabetic NephropathySingapore General HospitalPhase 3

See all Aspartame clinical trials

Clinical Trial Summary for Aspartame

Top disease conditions for Aspartame
Top clinical trial sponsors for Aspartame

See all Aspartame clinical trials

US Patents for Aspartame

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Aspartame See Plans and Pricing Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same Protalix Ltd. (Carmiel, IL) See Plans and Pricing
Aspartame See Plans and Pricing Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus Seattle Genetics, Inc. (Bothell, WA) See Plans and Pricing
Aspartame See Plans and Pricing Infusion methods and products Ocean Spray Cranberries, Inc. (Lakeville-Middleboro, MA) See Plans and Pricing
Aspartame See Plans and Pricing Granulation of a stevia sweetener PureCircle Sdn Bhd (Kuala Lumpur, MY) See Plans and Pricing
Aspartame See Plans and Pricing Pharmaceutical antiretroviral composition Cipla Limited (Mumbai, IN) See Plans and Pricing
Aspartame See Plans and Pricing Use of inhibitors of Bruton'S tyrosine kinase (Btk) Pharmacyclics LLC (Sunnyvale, CA) See Plans and Pricing
Aspartame See Plans and Pricing Use of inhibitors of Bruton's tyrosine kinase (Btk) Pharmacyclics LLC (Sunnyvale, CA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Aspartame

Drugname Country Document Number Estimated Expiration Related US Patent
Aspartame Australia AU2013366898 2032-12-28 See Plans and Pricing
Aspartame Brazil BR112015015275 2032-12-28 See Plans and Pricing
Aspartame Canada CA2896701 2032-12-28 See Plans and Pricing
Aspartame China CN104884447 2032-12-28 See Plans and Pricing
Aspartame China CN107698555 2032-12-28 See Plans and Pricing
Aspartame Denmark DK2940013 2032-12-28 See Plans and Pricing
Aspartame Denmark DK3360869 2032-12-28 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Mallinckrodt
Merck
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.